Skip to content
★ Sign in to follow
Jilin Jian Yisheng Pharmaceutical Co., Ltd. logo

Jilin Jian Yisheng Pharmaceutical Co., Ltd. Stock: price and insider trades · China

益盛药业

CN·Mcap CN¥2.2BHealth Care

Jilin Jian Yisheng Pharmaceutical Co., Ltd.: what insiders have been doing

Jilin Jian Yisheng Pharmaceutical Co., Ltd. has a thin disclosure history in our data (latest filing: 6 June 2025). New filings will appear here as soon as they are published. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.

Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€399,903
1 ops. · all time

Who traded when

BuySale
薛晓民1 sale

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 17,425 of 26,897 companies
42.0
score / 100
Value
36
Quality
48
FCF yld3.8%
Earn yld1.3%
EV/EBITDA31.0x
ROE1.6%
Gross mgn74%
Net mgn4.5%
Debt/EBITDA5.0x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥6.70
Analyst consensus
·
Income statement
RevenueCN¥640.2M
Gross profitCN¥473.7M74% margin
EBITDACN¥85.4M13% margin
Net incomeCN¥29M5.7% margin
Valuation
PER (trailing)60.9x
P/Book1.0x
Beta0.19
Balance sheet & cash
Market capCN¥2.2B
Total debtCN¥426M
Free Cash FlowCN¥85.1M
Debt / Equity21%
Profitability & ownership
ROE1.6%
ROA0.3%
% insiders48.4%
% institutions4.8%
Last declaration on 6 June 2025
Declarations1 total
  • ▼
    高管Executives
    3M CNY19SZSE
    416,100 shares100.0% of flowA股XSHESZSE:173000009047597660

1 of 1 declaration

About Jilin Jian Yisheng Pharmaceutical Co., Ltd.

益盛药业 is a healthcare and pharmaceutical company listed on the XSHE market. It specializes in the development and production of innovative medications.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations